Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$27.35 - $40.45 $10,447 - $15,451
-382 Reduced 5.75%
6,256 $193,000
Q3 2023

Nov 14, 2023

BUY
$16.89 - $35.01 $6,418 - $13,303
380 Added 6.07%
6,638 $175,000
Q2 2023

Aug 10, 2023

BUY
$13.29 - $18.01 $4,943 - $6,699
372 Added 6.32%
6,258 $107,000
Q1 2023

May 15, 2023

SELL
$7.17 - $18.55 $6,467 - $16,732
-902 Reduced 13.29%
5,886 $97,000
Q4 2022

Jun 14, 2023

BUY
$6.74 - $11.52 $6,079 - $10,391
902 Added 15.32%
6,788 $51.7 Million
Q3 2022

Jun 14, 2023

BUY
$7.94 - $12.36 $7,161 - $11,148
902 Added 15.32%
6,788 $67.5 Million
Q2 2022

Jun 20, 2023

BUY
$5.21 - $12.14 $4,699 - $10,950
902 Added 15.32%
6,788 $61,000
Q1 2022

Jun 20, 2023

BUY
$7.34 - $17.16 $6,620 - $15,478
902 Added 15.32%
6,788 $68,000
Q1 2022

Mar 30, 2023

SELL
$7.34 - $17.16 $147,658 - $345,207
-20,117 Reduced 74.77%
6,788 $68,000
Q1 2022

May 12, 2022

SELL
$7.34 - $17.16 $147,658 - $345,207
-20,117 Reduced 74.77%
6,788 $69,000
Q4 2021

Jun 21, 2023

BUY
$11.38 - $53.41 $239,196 - $1.12 Million
21,019 Added 357.1%
26,905 $448,000
Q4 2021

Mar 30, 2023

SELL
$11.38 - $53.41 $17,752 - $83,319
-1,560 Reduced 5.48%
26,905 $448,000
Q4 2021

Feb 15, 2022

SELL
$11.38 - $53.41 $17,752 - $83,319
-1,560 Reduced 5.48%
26,905 $449,000
Q3 2021

Jun 21, 2023

BUY
$46.87 - $64.24 $1.06 Million - $1.45 Million
22,579 Added 383.61%
28,465 $1.33 Million
Q3 2021

Mar 30, 2023

SELL
$46.87 - $64.24 $41,198 - $56,466
-879 Reduced 3.0%
28,465 $1.33 Million
Q3 2021

Nov 15, 2021

SELL
$46.87 - $64.24 $41,198 - $56,466
-879 Reduced 3.0%
28,465 $1.33 Million
Q2 2021

Jun 21, 2023

BUY
$46.47 - $63.93 $1.09 Million - $1.5 Million
23,458 Added 398.54%
29,344 $1.79 Million
Q2 2021

Mar 30, 2023

BUY
$46.47 - $63.93 $179,420 - $246,833
3,861 Added 15.15%
29,344 $1.79 Million
Q2 2021

Aug 16, 2021

BUY
$46.47 - $63.93 $1.36 Million - $1.87 Million
29,319 Added 117276.0%
29,344 $1.79 Million
Q1 2021

Jun 26, 2023

BUY
$55.47 - $72.35 $1.09 Million - $1.42 Million
19,597 Added 332.94%
25,483 $1.57 Billion
Q1 2021

Mar 30, 2023

BUY
$55.47 - $72.35 $248,394 - $323,983
4,478 Added 21.32%
25,483 $1.57 Million
Q1 2021

May 14, 2021

SELL
$55.47 - $72.35 $1.16 Million - $1.52 Million
-20,980 Reduced 99.88%
25 $1.57 Million
Q4 2020

Jun 22, 2023

BUY
$38.38 - $71.11 $580,267 - $1.08 Million
15,119 Added 256.86%
21,005 $1.49 Million
Q3 2020

Jun 26, 2023

BUY
$27.2 - $42.19 $411,236 - $637,870
15,119 Added 256.86%
21,005 $788,000
Q3 2020

Mar 30, 2023

SELL
$27.2 - $42.19 $46,022 - $71,385
-1,692 Reduced 7.45%
21,005 $788,000
Q3 2020

Nov 13, 2020

SELL
$27.2 - $42.19 $46,022 - $71,385
-1,692 Reduced 7.45%
21,005 $788,000
Q2 2020

Jun 26, 2023

BUY
$22.22 - $35.69 $373,540 - $599,984
16,811 Added 285.61%
22,697 $740,000
Q1 2020

Jul 12, 2023

BUY
$16.11 - $36.23 $270,825 - $609,062
16,811 Added 285.61%
22,697 $658,000
Q1 2020

Mar 30, 2023

BUY
$16.11 - $36.23 $244,920 - $550,804
15,203 Added 202.87%
22,697 $658,000
Q1 2020

May 15, 2020

BUY
$16.11 - $36.23 $244,920 - $550,804
15,203 Added 202.87%
22,697 $658,000
Q4 2019

Jul 12, 2023

BUY
$17.96 - $46.63 $28,879 - $74,981
1,608 Added 27.32%
7,494 $262,000
Q4 2019

Mar 30, 2023

SELL
$17.96 - $46.63 $59,914 - $155,557
-3,336 Reduced 30.8%
7,494 $262,000
Q4 2019

Feb 14, 2020

SELL
$17.96 - $46.63 $59,914 - $155,557
-3,336 Reduced 30.8%
7,494 $263,000
Q3 2019

Jul 12, 2023

BUY
$20.13 - $32.38 $99,522 - $160,086
4,944 Added 84.0%
10,830 $232,000
Q3 2019

Mar 30, 2023

BUY
$20.13 - $32.38 $81,365 - $130,879
4,042 Added 59.55%
10,830 $232,000
Q3 2019

Nov 14, 2019

BUY
$20.13 - $32.38 $218,007 - $350,675
10,830 New
10,830 $233,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.31B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.